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To identify predictors of the success or failure of medical
therapy in chronic recurrent sustained ventricular
tachycardia, univariate and multivariate statistical tech-
niques were used to retrospectively analyze data in 84
patients with this arrhythmia. By univariate analysis,
four factors were associated with successful medical
treatment: age lessthan 45 years, ejection fraction greater
than 50%, hypokinesia as the only contraction abnor-
mality and the absence of organic heart disease. Four
other findings, the induction of ventricular tachycardia
with a single ventricular extrastimulus, an HV interval
greater than 60 ms, the presence of a left ventricular
aneurysm and Q waves on a baseline electrocardiogram,
correlated with medical failure. However, none of these
variables alone accurately predicted treatment results in
more than 75% of cases.
In recent years there have been major increases in our knowl-
edge of the mechanisms of chronic recurrent sustained ven-
tricular tachycardia and in our approaches to the medical
and surgical therapy of this life-threatening arrhythmia (1-
13). Electrophysiologic testing, using programmed ventric-
ular stimulation, has proved to be a valuable method of
accurately assessing the effectiveness of both pharmacologic
and surgical interventions; moreover, the inability to induce
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By discriminant analysis, a function incorporating
eight variables was constructed which correctly classified
81% of patients. Moreover, three-quarters of the pa-
tients could be classified into groups with a high or low
probability of success where accuracy increased to 90% •
When the discriminant function was tested prospectively
in 31 similar patients, 25 (81%) fell into the groups with
a high or low probability of success. In the latter group,
of 20 patients predicted to fail medical therapy, 19 (95%)
did fail a complete trial of medical therapy. The overall
accuracy remained a high 92%. In clinical application
this function would allow patients with a high probability
of responding to medical therapy to be selected for serial
electrophysiologic drug testing. In patients with a low
probability of responding to medicaltherapy, serial studies
could be avoided and alternate forms of therapy explored.
ventricular tachycardia by programmed stimulation follow-
ing any intervention has correlated with the long-term suc-
cess of therapy (4-6,10-12). Electrophysiologic studies
are. however, invasive, psychologically stressful and, par-
ticularly in drug-resistant patients, time consuming. In ad-
dition, each therapeutic intervention carries potentially toxic
side effects and a finite morbidity and mortality. If factors
predictive of the success or failure of medical or surgical
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therapy could be identified, treatment selections likely to
fail could be avoided.
Although it has been known since the 1930s that sus-
tained ventricular tachycardia occurs predominantly in the
setting of chronic ischemic heart disease (14-18), the re-
lation between anatomic factors in patients with ventricular
tachycardia and the success or failure of pharmacologic
therapy has not been previously examined. In the present
study, we used univariate and multivariate statistical tech-
niques to analyze clinical, arteriographic, angiographic,
hemodynamic and electrophysiologic variables from a large
group of patients with this arrhythmia who underwent med-
ical treatment to determine whether predictors of the out-
come of medical therapy could be identified and quantified.
Methods
Data Collection
Patients. Between January 1978 and February 1980 we per-
formed electrophysiologic studies in 120 patients with chronic
recurrent sustained ventricular tachycardia. One hundred of these
patients also underwent routine cardiac catheterization. In 84 pa-
tients (62 from the Hospital of the University of Pennsylvania and
22 patients from other institutions) complete angiographic and
hemodynamic data were available; these patients form the basis
of this report. In all cases cardiac catheterization and electro-
physiologic study were performed with patients in the nonsedated,
postabsorptive state (after obtaining informed written consent).
Cardiac catheterization. Coronary arteriograms were per-
formed by either the Sones or Judkins technique and reviewed
independently by at least two observers without knowledge of
clinical history or ventricular function. Differences were settled by
consensus. Vessels were graded as either less than 70% stenosed.
greater than or equal to 70% stenosed or 100% occluded. The
extent of disease involving the left main, left anterior descending,
left circumflex and right coronary arteries was determined. Sten-
oses of diagonal branches of the left anterior descending coronary
artery were excluded from analysis. Incases of serial lesions within
the same artery, only the most severe lesion was graded.
To analyze segmental wall motion abnormalities by ventric-
ulography the right anterior oblique projection was divided into
anterior, apical and inferior segments; when available the left an-
terior oblique projection was divided into septal and posterolateral
segments. Segments were graded as hypokinetic, akinetic, para-
doxical or both according to standard definitions (19). Ejection
fraction was calculated using the single plane area-length method
(20). Cardiac output was calculated by either the dye-dilution or
Fick method (21).
EIectrophysioIogic studies. These studies began after antiar-
rhythmic medications had been discontinued for at least five half-
lives. Two to six electrode catheters were inserted percutaneously
or by cut-down through femoral or brachial veins, or both, and
positroned in the heart under fluoroscopic guidance. Typically,
catheters were placed in the right atrium, His bundle recording
site, coronary sinus and right ventricular apex. The stimulation
protocol, previously published in detail (3), included the intro-
duction of single and double ventricular premature depolanzations
during sinus and ventricular paced rhythm and rapid ventncular
pacing to a cycle length of 250 ms in all patients. Triple ventricular
premature depolarizations were introduced during sinus and ven-
tricular paced rhythm in 17 patients. In patients in whom the
tachycardia could not be initiated from the right ventricular apex,
the stimulation protocol was repeated using a catheter positioned
in the right ventricular outflow tract. In 10 patients ventricular
tachyardia could not be induced from any site III the right ventricle;
in these patients, left ventricular stimulation, using an identical
protocol, was performed using an electrode catheter passed per-
cutaneously through the femoral artery or by brachial arteriotomy
to the left ventricle under systemic heparinization.
Antiarrhythmic drug therapy. To determine antiarrhythmic
drug efficacy, each patient received all available noninvestigational
drugs, alone or in combination, except where contramdicated be-
cause of known allergy, hemodynamic compromise (for example,
ejection fraction less than 30% for disopyramide and propranolol)
or prior clinical recurrence of ventricular tachycardia at the highest
tolerated doses. The following standard antiarrhythmic agents were
tested: procainamide, quinidine, lidocaine, phenytoin, disopyr-
amide, propranolol and phenytoin combined with either quinidine
or procainamide. During the time frame of this study, only two
investigational agents, aprindine and amiodarone, were available
to our laboratory. These two drugs were tested in only three pa-
tients. The dosage of each drug or drug combination was increased
until the arrhythmia became noninducible in the laboratory or until
side effects appeared. There was no statistically significant dif-
ference in the mean (±: standard deviation) number of drug trials
between the patients treated successfully with medical therapy
(2. 19 + 1.43) and those who failed medical therapy (2.80 +
1.53).
Definitions
Medical success was defined as the inability to induce ventric-
ular tachycardia by electrophysiologic testing on an oral drug reg-
imen. Medical failure was defined as the inability to find a drug
or drug combination which prevented inrtiation of ventricular
tachycardia in the laboratory.
C finical follow-up was obtained through outpatient arrhythmia
clinic visits, telephone contact WIth patients and their physicians
and responses to yearly questionnaires. The circumstances of all
deaths were investigated as thoroughly as possible employing Ill-
terviews with observers, medical and hospital records and available
postmortem examinations. Follow-up was terminated if any change
was made in the recommended antiarrhythmic drug regimen. Suc-
cess during long-term follow-up was defined as the absence of
sustained palpitation, syncope, electrocardiographically docu-
mented sustained ventricular tachycardia or sudden death (that is,
within I hour of symptoms). Failure during long-term follow-up
was defined as the recurrence of sustained palpitation, syncope,
sustained ventricular tachycardia or sudden death. Non-sudden
cardiac deaths or deaths from other disease processes were not
counted as failures of medical therapy for ventricular tachycardia.
Data Analysis
Predictive variables. The goal of the analysis was to deter-
mine which variables were independently predictive of medical
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success or failure and from which predictive models could be
developed. Seventy-three independent variables of potential pre-
dictive value were initially identified. These mcluded age. sex.
cardiac diagnosis. initial symptom of ventricular tachycardia. elec-
trocardiographic pattern. ejection fraction. cardiac output. cardiac
index. left ventricular end-diastolic pressure. extent of coronary
artery disease. contraction pattern. AH and HV intervals. mode
of initiation. mode of termination of ventricular tachycardia and
tachycardia cycle length. The correlation between these indrvidual
variables and the results of medical treatment were analyzed using
the chi-square test with Yates' correction factor or Fisher' s exact
test for dichotomous variables and the Student' s t test for unpaired
data for continuous variables. Probability (p ) values were calcu-
lated for each correlation. Table I defines sensmvity, specificity ,
positive predictive value. negative predictive value and accuracy
for this study.
The restriction of the data on mode of termination of ventricular
tachycardia to 65% of the patient population led us to exclude it
from further analysis. All variables that were predictive of success
or failure at p :s 0.20 were entered into a stepwise linear discrim-
inant analysis using the Statistical Package for the Social Sciences
(SPSS) Programs (22). The final stepwise discriminant analysis
included all variables that were at least marginally predictive of
success or failure (F 2: 2.0 ). The power of the derived function
was subsequently tested in an additional 31 patients with ventric-
ular tachycardia studied consecutively between April and October
of 1980.
Discriminant analysis. Stepwise discrirnmant analysis Iden-
tifies and collects those discriminating variables that most usefully
measure the characteristics upon which groups are expected to
differ. Its objective is to maximize separation of two or more
groups by weighing and combining discriminating variables in
some linear form. By applymg a user-selected criterion, the single
best discriminating variable is selected. Then all remaining po-
tential variables are tested. The variable that is best able to improve
the value of the discrimination criterion in combination with vari-
ables selected is then chosen. Subsequent variables are further
Table 1. Statistical Definitions
selected by their marginal contributions to further discrimination.
At each test previously selected variables are reexamined. If a
variable reduces discrimination when combined with subsequently
selected variables it is removed. Additional variables are included
until those remaining no longer make significant contributions to
further discrimination. The discriminant function's ability to clas-
sify cases correctly is measured by standard statistical tests. The
magnitude of each coefficient in the resultant discriminant function
reflects the unit of measurement of each variable as well as its
relative contribution (22) .
Results
General Characteristics
The clinical profiles of the study population are sum-
marized in Table 2. Sixty-nine patients (82%) had coronary
artery disease with electrocardiographic evidence of prior
myocardial infarction present in 59 (70%). Twenty-three
patients (33%) had single vessel disease, 27 (39%) two
vessel disease and 19 (28%) three vesse l disea se (Table 3) .
At least one vessel was totally occluded in 55 patients (79%).
The left anterior descending coronary artery was the most
commonly diseased vessel and was totally occluded in 49%
of the patients. Ventricular functon was generally poor with
a mean ejection fraction for the group of 33 .0 ± 16.1%
(standard deviation). Fifty-one patients (6 1%) had a left
ventricular aneurysm, 38 (74%) of whom also had additional
contraction abnormalities. Akinetic areas without aneury sm
were present in 12 patients (14%).
In the majority of cases (59 of 84 , 71% ) ventr icular
tachycardia was induced by programmed stimulation in the
control state with single or double ventricular extrastimuli
(Table 4). In 10 patients (12%), the clinical tachycardia
could only be initiated with left ventricular stimulation.
Tru e posruve (T P) = Failure, with vanablc
False posit ive (FP) = Successes wit h vana ble
True negati ve (TN) = Successes without van ablc
False neganve (FN) = Failures without vanable
Failures with vana ble
Sensitivity = -------
All failure s
TP
TP + FN
S
. . Successes without vana ble
pecifi city = ------~..:..::..::.:..:.
All successes
. . . . Failu res with vana ble
Positive pred icti ve value = --------
All patrents with vanable
N
. . Successes Withou t van able
ega nve predictive value = ~-------­
All pattent s Without van able
TN
TN + FP
TP
TP + FP
TN
TN + FN
A
Sum of failures WIth van able and successes Without vanable TP + TN
ccuracy =
All patients All tests
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Table 3. Angiographic and Hemodynamic Data
* Undocumented In 13 patients t Mean (range)
BBB = bundle branch block, CAD = coronary artery disease, HD = heart
disease. (VCD = mtraventncular conduction delect
*Refers to percent of patients with coronary artery disease t Mean ± standard
deviation
CI = cardiac Index; EF = ejection fraction. LVEDP = left ventncular end-
diastolic pressure.
Table 2. Clinical Characteristics of 84 Patients
Charactenstics No. '1c
Cardiac diagnosis
CAD 69 82
NoHD 6 7
Other HD 9 II
ECG
Q waves 59 70
IVCD \8 2\
BBB 16 19
Initial symptoms*
Palpitation 40 48
Presyncope 3 4
Syncope II 13
Cardiac arrest 16 19
Pulmonary edema I I
Age (yr) 54 16-73"r
23 (28lkrr
36 (4Wr r;'
18 (21 '1c r;'
7( slkr;'
10 (129rr;'
90 ± 20
62 ± 18
308 ± 78
Basal AH Interval (rnv)
Basal HV Interval (rns)
VT; cycle length (rns)
VI. mode of induction
SVES
DVES
Other
NI
LV only
Table 4. Electrophysiologic Data
, Mean ± standard devrauon t Number of pauents and percent 01 group
DVES = double ventncular extrasumuh, LV = left ventncle. NI = OOnlO-
ducible, SVES = single ventncular exrrasumuh, VT = ventricular tachycardia
tients to be classified as successes or failures with an ac-
ceptable accuracy. The presence of an aneurysm had a sen-
sitivity of 73%, a specificity of 62%, a positive predictive
value of 78% and a negative predictive value of 55% with
an overall accuracy of 69%. Ejection fraction less than 50%
had a high sensitivity of 98%, a low specificity of 30%, a
positive predictive value of 72% and a negative predictive
value of 89% with an accuracy of 74% (the best of any
individual variable). The combination of two factors, left
ventricular aneurysm and induction of ventricular tachy-
cardia with a single extrastimulus, was highly discriminat-
ing, having a specificity of 100% and a positive predictive
value of 100%. However, this combination was seen in only
17 patients (21%) so that sensitivity and overall accuracy
remained low at 31% and 55%, respectively.
Multivariate analysis. Because no single variable ad-
equately predicted therapeutic outcome, the ability of mul-
tiple variables to predict medical success or failure was then
tested in the stepwise discriminant analysis. The eight vari-
ables selected in the final discriminant analysis in order of
decreasing power are listed in Table 6. Patients were clas-
sified by the computer as manifesting "success" when the
probability of medical success was 50% or greater, corre-
sponding to a discriminant score of - 0.5 or less, and as
manifesting "failure" when the probability of medical suc-
cess was less than 50%, corresponding to a discriminant
score greater than - 0.5. The sensitivity of the function was
91% (50 of 55 patients), specificity 62% (18 of 29), positive
predictive value 82% (50 of 61) and negative predictive
value 78% (18 of 23). Eighty-one percent of all cases were
classified correctly by the discriminant function compared
with 74% by the best individual variable.
Application of discriminant score. More importantly,
if the function was not limited to a binary outcome and was
used instead to classify patients as having a high, low or
intermediate probability of a successful response to medical
therapy, its usefulness increased (Fig. I). Seventy-one per-
cent of the patients (60/84) were classified into either a low
or high probability group which was defined by discriminant
scores greater than 0.11 and less than - 0.76, respectively.
The predictive value for medical failure of a discriminant
score greater than 0.11 was 90% (37 of 41 patients), the
23 33*
27 39·
19 2S*
51 61
12 14
II 13
33.0 ± 16.It
2.8 ± O.8t
16.7 ± 77t
No.Data
2"70% stenosis
I vessel disease
2 vessel disease
3 vessel disease
Aneurysm
Akinesia
Hypokinesia
EF (%)
CI (liters/min per m')
LVEDP (mm Hg)
Statistical Analysis
Predictive variables. Medical treatment was attempted
in all 84 patients, In only 29 (35%) of the 84 patients could
a successful medical regimen be defined. In patients with
coronary artery disease and left ventricular aneurysm the
success rate fell to 22%. Eight individual variables were
found to be significantly associated with the success or fail-
ure of medical therapy (Table 5). Four factors correlated
with medical success: age less than 45 years. ejection frac-
tion greater than 50%, hypokinesia as the only contraction
abnormality and the absence of organic heart disease. In-
duction of ventricular tachycardia with a single ventricular
extrastimulus, an HV interval greater than 60 ms, the pres-
ence of a left ventricular aneurysm and Q waves on a base-
line electrocardiogram correlated with medical failure. There
was no relation between pharmacologic success and either
hemodynamic variables or the extent of coronary artery
disease.
Univariate analysis. No individual variable allowed pa-
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Variable Vanable Present* Variable Absent* p Value
Age :545 yr 69 (9113) 28 (20171) O.QI
ECG: Q waves 27 (16/59) 52 (13/25) 0.05
ECG: AMI 25 (10/40) 43 (19/44) 0.\3
Coronary artery disease 30 (21/69) 53 (8/15) 0.16
No heart disease 83 (5/6) 31 (24/78) 0.03
Cardiac index :52 0 liters/min per m2 36 (4/11) 22 (12/55) oes
EF >50% 89 (8/9) 28 (19/69) Q.GI
LAD :2:70% stenosis 27 (14/52) 47 (15/32) 0.10
:2:70% stenosis
I vessel disease 30 (7/23) 36 (22/61) 0.82
2 vessel disease 30 (8127) 37 (21/57) o.ss
3 vessel disease 32 (6/19) 35 (23/65) 0.97
Aneurysm 22 (II/51) 55 (18/33) 0.004
Akinesia 25 (3/12) 36 (26172) 0.60
Hypokinesia 55 (6111) 32 (23173) 0.03
HV interval >60 ms 21 (8/39) 47 (21/45) 0.Q2
VT inducible with SVES 13 (3/23) 43 (26/61) 0.02
* Values are listed as % (number of successes/number of patients With or Without variable).
AMI = antenor myocardial infarction; ECG = electrocardiogram, EF = ejection fraction; LAD = left antenor descending coronary artery; p = probability; SVES =
Single ventncular extrastimuh; VT = ventncular tachycardia
predictive value for medical success of a discriminant score
less than - 0.76 was 89% (17 of 19) and overall accuracy
was 90% (54 of 60).
This function was subsequently applied prospectively to
an additional 31 patients with recurrent ventricular tachy-
cardia (Fig. 2). Only six of these cases (19%) were in the
indeterminate zone. Nineteen (95%) of the 20 patients in
the low probability of success group were correctly iden-
tified as medical failures and 4 (80%) of 5 patients in
the high probability of success group were correctly iden-
tified as medical successes, yielding an overall accuracy of
92%. The single misclassification in the low probability
Table 6. Discriminant Analysis: Medical Therapy*
group was an atypical patient with a left ventricular aneu-
rysm secondary to sarcoidosis.
Clinical Follow-up
Of the 29 patients in whom a successful medical regimen
could be defined in the laboratory, 2 elected arrhythmia
surgery despite medical success and 27 were discharged on
the recommended drug regimen. Through a mean follow-
up period of 18 months (range 3 to 38) 85% of these patients
(23 of 27) remained free of ventricular tachycardia; 4 pa-
tients died suddenly.
Forty-one ofthe 55 patients classified as medical failures
Variable Variable Value Function Coefficient Ok Variance
Aneurysm I = present; 0.873 106
o = absent
EF >50% I = present; -0.937 li.2
o = absent
Posterobasal hypokinesia I = present; -1.403 8.2
o = absent
Induction with SVES I = present; 0.642 5.6
o = absent
HV interval >60 ms I = present; 0.660 5.3
o = absent
Coronary artery disease I = present; -1.876 7.1
o = absent
Pnmary electrical disease I = present; -1.560 6.7
o = absent
Age Years 0.021 3.9
* To denve the discnrrnnant score. each vanable value IS rnultrphed by ItS appropriate coetficient These products are summed and the constant - 0080 ts added. The
score IS then placed on the probability curve in Figure I to obtain the probabihty that the patients Will be successfully treated With medical therapy
The eight vanables are listed In order of decreasing discnrninanng power and the percents of variance accounted lor by each van able are listed In the nght column
EF = ejection fraction: SVES = Single ventncular extrasnmuh
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Figure 1. Probability of medical success based
on discrim inant score. The percent probabil ity
of medical succe ss is plotted on the ordinate
and the discriminant sco re on the abscissa for
each patient. The open triangles represent
medic al success and the closed circles med ical
failure . The indetermmate zone is defined by
discriminant score s between 0 .11 and - 0 .76
and by probabilities between 21.6 and 62 .8%
This definition was arbitrarily selected to max-
imize the number of patients in the high and
low probabi lity groups and maintain the pre-
dictive accuracy of the function at 90% or
greater.
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DISCRIMINANT SCORE
underwent arrhythmia surgery (9.10). Operation was suc-
cessful in eliminating ventricular tachycardia in 32 of these
patients and 30 (94%) have remained free of ventricular
tachycardia through a mean follow-up period of 17 months
(range 3 to 37) . Two patients have suffered recurrences of
ventricular tachycardia without hemodynamic compromise.
Surgery was unsuccessful in the remaining nine patient s,
five of whom died intraoperatively and four of whom had
ventric ular tachycardia that remained inducible post-
operatively .
Fourteen of the patients classified as medical failures did
not undergo surgery and were discharged on the medication
that made their arrhythmia most difficult to initiate in the
laboratory. During a mean follow-up period of II months
(range I to 51), 9 (64%) of the 14 either had recurrences
of ventricular tachycardia (5 patients) or died suddenly (4
patients). The remaining five medical failure patients con-
tinued to do well without ventricular tachycardia; three of
these patients are receiving amiodarone, a new agent for
the treatment of recurrent ventric ular tachycardia.
Discussion
Rationale of the st udy. Serial electrophysiologic testing
has been shown to be of value both in the selection of
antiarrh ythmic drug therapy and in the determination of
prognosis for patient s with recurrent sustained ventricular
tachycardia (4-6,11 ,12). In fact , several studies have es-
tablished that prediction of the success and failure of therapy
by laboratory studies correlates closely with clinical out-
come (that is, long-term success and failure) (11,12). How-
ever, as there has previously been no method of predicting
the results of electrophysiologic testing, in order to define
success or failure , patient s have routinely undergone serial
electrophysiologic studies on all standard and multiple ex-
perimental medications. This approach has several limita-
tions: 1) the increasing number of available antiarrhythmic
agents requires an increasing number of electrophysiologic
studies to define medical success or failure with a consequent
increase in the potential morbidity from the procedure and
the length of hospital stay; 2) electrophysiologic studies are
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Fig ure 2. Prospect ive testing of the discnmmant func-
tion . Discriminant scores for the 3 1 pat ients in the pro-
specnve group are plotted on the abscissa. The open tri-
angles represent medical success and the closed circles
medical failure . The area between the vertical broken
lines represent s the previously described indeterminate
zone . See text for further discu ssion .
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psychologically stressful and repeated testing consistently
leads to severe patient depression and difficult physician-
patient relations, particularly in patients with medically re-
fractory tachycardias; and 3) the expense of repeated studies
is currently high and likely to increase.
This study was designed, therefore, to identify variables
predictive of medical success or failure using clinical and
baseline hemodynamic and electrophysiologic data so that
serial electrophysiologic testing could be avoided in patients
who have a high probability of failing medical therapy.
Identification of patients who cannot benefit from medical
therapy is especially important since effective surgery for
arrhythmia and antitachycardia pacemakers are now avail-
able for patients whose condition cannot be controlled with
medications (9,10).
Statistical analysis and clinical application. In order
to identify predictors of therapeutic outcome we initially
examined 73 individual variables. Medical success strongly
correlated with age less than 45 years, the absence of organic
heart disease, ejection fraction greater than 50% and hy-
pokinesia as the only contraction abnormality. Medical fail-
ure was associated with Q waves on electrocardiogram. the
presence of a left ventricular aneurysm, induction of ven-
tricular tachycardia with a single ventricular extrastimulus
and an HV interval greater than 60 ms. However, no in-
dividual variable was sensitive or specific enough to be of
clinical value. The best individual variable (ejection fraction
less than 50%) was only 74% accurate in properly classi-
fying patients.
A discriminant junction incorporating eight variables was
constructed which predicted the response to medical therapy
with 90% accuracy in three-quarters of the patient pop-
ulation. One-quarter of the patients fell into an intermediate
group in which the response to medical therapy could not
be predicted with any degree of certainty. When the func-
tion was applied prospectively to a second group of 31
patients with ventricular tachycardia. 25 (81% ) were clas-
sifi ed with 92% accuracy. Most importantly, 95% of the
patients predicted to fail medical therapy did in fact fail;
extensive serial electrophysiologic testing could have been
avoided in these patients based upon the discriminant score.
111 clinical application this function would allow patients
with a high probability of responding to medical therapy to
be selected for serial electrophysiologic testing. A second
group of patients with a low probability of responding to
medical therapy could also be identifi ed and directed to other
alternatives: to surgery, if operative candidates, or to pace-
maker therapy or newer experimental agents such as amio-
darone, if surgery was not possible or not desired by the
patient or, failing these options, to implantable defibrilla-
tors. For patients in the intermediate group a decision as to
which therapy to select would depend upon the physician's
Judgment of the relative risks involved and the patient' s
preferences.
Limitations of study. The results of any analysis of this
type are largely dependent upon patient selection (that is,
type and severity of heart disease) and the individual lab-
oratory's protocol. The vast majority of our patients had
coronary artery disease and were referred for electrophys-
iologic study following multiple recurrences of ventricular
tachycardia considered refractory to medical therapy. This
study group did not include patients treated successfully on
a " trial and error" basis or patients considered too unstable
to survive transfer. Therefore, prospective testing of the
discriminant function in patients drawn from a community
hospital setting would be necessary to evaluate general
applicability of the scoring system.
Moreover, on the basis of previously published data (4 -
6, 11,12) and the follow-up data from our own patients, this
study assumes a good correlation between the results of
medical therapy as defined in the laboratory and long-term
clinical results. Therefore, the analysis would not apply to
an antiarrhythmic agent such as amiodarone for which this
correlation could not be demonstrated (23). In our own study
population, for instance, three of fi ve patients originally
classified as medical failures remain without ventricular
tachycardia during long-term follow-up on amiodarone. It
is clear, therefore, that this analysis would require revali-
dation in a patient population tested extensively on exper-
imental agents.
We thank Helaine M. Corr and Rob yn Borland oe fo r their sec retaria l
assistance and Robert Lang and Sandra Rosenberg for their computer
ass ista nce In the preparat ion of this manu script .
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